THE LANCET: Treating COVID-19 infection with molnupiravir does not decrease deaths or hospital admission in high-risk, vaccinated patients, but can lead to quicker recovery
Peer-reviewed / Randomised Controlled Trial / People Randomised controlled trial with over 25,000 participants suggests that using the antiviral, molnupiranir, ...